Strados Labs is at the forefront of respiratory health technology, specializing in innovative wearable devices for remote monitoring. Their flagship product, the RESP® Biosensor, is the first FDA-cleared wearable stethoscope that continuously captures and analyzes lung sounds, effectively detecting coughs and wheezes. This groundbreaking device allows healthcare providers to manage patient lung health from hospital to home by providing real-time data on respiratory symptoms, which enhances treatment plans and clinical studies.

Founded with a vision to improve respiratory care, Strados Labs has established itself as a leader in digital health solutions. The company employs advanced technology that includes a mobile app and cloud storage to securely track lung sound events, ensuring patient data privacy through encryption and enhanced noise filtering. With validated accuracy against traditional stethoscopes and usage across four continents in multiple languages, Strados Labs continues to revolutionize how healthcare practitioners gather insights into their patients' lung health, ultimately aiming to "Make Every Breath Count."